EGO Pharmaceuticals took home a haul of five Consumer Health Products Australia (CHP) Self-Care Excellence Awards on Wed, including the Most Trusted Partner in Pharmacy (over $100 million), which it shared with iNova Pharmaceuticals.
The company landed the Quality Use of Medicines (QUM) Excellence (over $100 million) Award, while claiming the CHP's two new honours, the Innovative Manufacturing Solution Award, for its water diversion initiative, and the Environmental Sustainability Award, for its etchðos range.
Ego's etchðos products also landed the Outstanding and Innovative New Consumer Healthcare Product Award.
Church & Dwight took out the Most Trusted Partner in Pharmacy (under $100 million) and the QUM Excellence (under $100 million) Awards.
Allergan landed the Most Perferred Supplier (under $100 million) Award, while generics and private label over-the-counter medicine giant, Arrotex Pharmaceuticals took home the Most Preferred Supplier (over $100 million) title.
CHP CEO, Dr Deon Schoombie, said the Self-Care Excellence Awards recognised marketing and sales best practice, new products, manufacturing innovation and, sustainability initiatives which have contributed to excellence in self-care.
"Our judges are always looking to reward leading-edge creative work, innovation and best practice, and it is encouraging to see that even in such a turbulent year, the field was particularly competitive," he said.
"I encourage the industry to continue to strive for excellence over the coming year."
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Nov 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Nov 22
